Novinky na Forexu
Warren Buffett's Berkshire Hathaway Cuts Stake In Apple
Warren Buffett's Berkshire Hathaway has trimmed a portion of its significant stake in tech giant Apple Inc., reportedly citing tax reasons. As per its first-quarter earnings report released over the weekend, Hathaway's Apple stock was worth $135.4 billion as of March 31, 2024. This is lower than the $174.3 billion worth Apple stock as of December 31, 2023.
RTTNews |
Před 197 dny
Cohen & Co. Swings To Net Profit In Q1; Revenues Soar
Financial services company Cohen & Co. Inc. (COHN) reported Monday net income attributable to Company for the first quarter of $2.02 million or $1.28 per share, compared to a net loss of $2.64 million or $1.77 per share in the prior-year quarter.
RTTNews
|
Před 197 dny
Eurozone Private Sector Growth Accelerates In April
The euro area private sector growth accelerated to an 11-month high in April driven by the service sector, final survey results from S&P Global showed on Monday. The HCOB composite output index rose to 51.7 in April from 50.3 in the previous month. The flash estimate was 51.4.
RTTNews
|
Před 197 dny
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator
Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews
|
Před 197 dny
BioAtla Says FDA Clears IND Application For BA3361 For The Treatment Of Multiple Tumors
Biotechnology company BioAtla, Inc. (BCAB) announced Monday that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate BA3361 (CAB-Nectin-4) antibody drug conjugate (ADC) for the treatment of multiple tumor types.
RTTNews
|
Před 197 dny
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation
Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews
|
Před 197 dny
Bay Street Likely To Open On Firm Note
Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews
|
Před 197 dny
more news
Healthcare Realty Inks Strategic JV Relationship Deal With KKR
Healthcare Realty Trust Inc. (HR) announced Monday that it has entered into a strategic joint venture (JV) relationship with KKR & Co. Inc.(KKR) to jointly own and invest in quality medical outpatient buildings.
RTTNews
|
Před 197 dny
BioNTech Slips To Loss In Q1
Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews
|
Před 197 dny
Eurozone Sentix Investor Confidence Rises For 7 Straight Months
Eurozone investor confidence improved for the seventh straight month in May to hit the highest level since February 2022 as both current situation and expectations rose in small but steady steps, a closely watched survey showed on Monday. The investor confidence index posted -3.6 in May, the behavioral research institute Sentix reported. The score was forecast to improve moderately to -4.8.
RTTNews
|
Před 197 dny
Sensex, Nifty Give Up Early Gains To End Narrowly Mixed
Indian shares gave up early gains to end on a flat note Monday amid signs of escalating tensions in the Middle East.
RTTNews
|
Před 197 dny
European Shares Gain On Solid Data, Rate Cut Hopes
European stocks eked out modest gains on Monday as weaker-than-expected April U.S. jobs report released on Friday boosted the case for rate cuts by the third quarter.
RTTNews
|
Před 197 dny
CAC 40 Gains On US Rate Cut Optimism
French stocks were slightly higher on Monday as optimism over interest rate cuts returned to the fore, following weaker-than-expected U.S. jobs data released on Friday.
Also helping underpin sentiment, the latest HCOB PMI data produced by S&P Global showed that the French services economy began the second quarter of 2023 in expansion territory.
RTTNews
|
Před 197 dny
Stay up to date!
Add Zprávy to your browser
Add To Chrome
